LRCX·Lam Research Corporation
LRCX|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'27 | $2.18 | - | - |
| Q4'26 | $1.68 | $1.82 | +8.1% |
| Q3'26 | $1.36 | $1.47 | +7.8% |
| Q2'26 | $1.19 | $1.27 | +6.3% |
| Q3'25 | $1.22 | $1.26 | +3.3% |
| Q2'25 | $1.21 | $1.33 | +10.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'27 | $8.3B | - | - |
| Q4'26 | $6.8B | $6.7B | -1.1% |
| Q3'26 | $5.8B | $5.8B | +1.5% |
| Q2'26 | $5.3B | $5.3B | +0.0% |
| Q3'25 | - | $5.3B | - |
| Q2'25 | - | $5.2B | - |
LRCX|Monthly Returns
Market Data
LRCX Stock Snapshot
- Market cap
- 360.52B
- P/E ratio
- 49.6
- Day range
- $268.76 – $288.47
- News sentiment
- 63/100 · Bullish
- Analyst target
- $373.13 (+29.5%)
- Consensus
- Buy · 43 analysts
The chart on LRCX has not stabilised: price is in the middle of its 52-week range and the trend is still down. Coverage is deep enough that new information gets priced quickly, so surprises tend to be macro rather than fundamental.
Reverse DCF
What growth is priced into LRCX?
At today's price, Lam Research Corporation needs to grow free cash flow about 61.8% a year for the next 10 years to justify its valuation at a 13.55% cost of capital. Over its actual history it has compounded free cash flow at 19.6% a year, so the market is asking for 42.1 percentage points above its own delivered rate. On that basis LRCX looks priced above what its own growth record supports.
- Implied FCF growth
- 61.8%
- Historical FCF CAGR
- 19.6%
- Growth gap
- +42.1 pts
- Verdict
- RICH
- Discount rate (WACC)
- 13.55%
- Beta
- 1.74
Behaviour On Record
What LRCX's own history says about today's numbers
- Realized volatility (21d)
- 53.8% 87th pct
- Below its peak
- -33.6%
- vs 200-day average
- +7.8%
- Up days (1y)
- 53%
Lam Research Corporation is currently running 53.8% annualised volatility over the last 21 sessions. Measured against LRCX's own 13 years of daily returns rather than a market-wide average, that is the 87th percentile — elevated for this stock, against a typical reading of 34.3%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
LRCX is trading -33.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -23.0%, and the deepest was -56.8% in 2022. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +7.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 38th percentile — close to the gap it normally carries. Over the past year LRCX closed higher on 53% of sessions, and it is currently 2 sessions into a rising streak.
On September specifically: over 13 years of records, LRCX finished the month higher 6 of 13 times, with a median return of -0.8% and an average of +1.3%. Its strongest month historically has been May at +8.3% on average, its weakest August at -2.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: LRCX has opened more than 2% away from the prior close in 188 of 3,267 sessions (5.8% of the time), with the largest gaps running +6.5% and -6.1%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, LRCX moved an average of 6.9% in the session after earnings, closing higher 1 of those 3 times, with a median move of -2.8% and a largest of +13.6%.
All figures computed from 3,268 daily closes between 2013-09-20 and 2026-09-18, split-adjusted, recomputed daily. Percentiles are against LRCX's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of LRCX's sector?
Lam Research Corporation sits in the Technology sector, currently ranked 1st of 11 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #1 of 11
- Sector state
- Leading
- Sector rotation score
- 90
Analyst Rating Changes
Are analysts turning bullish or bearish on LRCX?
UBS most recently reiterated its rating on Lam Research Corporation to Buy on Sep 1, 2026 with a price target of $425 (from $435). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- UBS — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
LRCX Competitive Positioning
- LRCXyou're hereLam Research Corporation$360.5B+0.23%
- AMATApplied Materials, Inc.$352.8B+5.09%
- KLACKLA Corporation$231.2B+3.25%
- TERTeradyne, Inc.$58.1B-0.35%